Page last updated: 2024-10-30

leflunomide and Histiocytosis, Non-Langerhans-Cell

leflunomide has been researched along with Histiocytosis, Non-Langerhans-Cell in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Histiocytosis, Non-Langerhans-Cell: Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lonsdale-Eccles, AA1
Haworth, AE1
McCrae, FC1
Young-Min, SA1
Broadwell, AW1
Calamia, KT1
Kransdorf, MJ1
Ginsburg, WW1

Other Studies

2 other studies available for leflunomide and Histiocytosis, Non-Langerhans-Cell

ArticleYear
Successful treatment of multicentric reticulohistiocytosis with leflunomide.
    The British journal of dermatology, 2009, Volume: 161, Issue:2

    Topics: Aged; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide;

2009
Healing of erosive disease in multicentric reticulohistiocytosis.
    The Journal of rheumatology, 2010, Volume: 37, Issue:6

    Topics: Drug Therapy, Combination; Etanercept; Finger Joint; Histiocytosis, Non-Langerhans-Cell; Humans; Imm

2010